A synergetic effect of BARD1 mutations on tumorigenesis
Mutations in the BARD1 gene have been identified as risk factors in breast and ovarian cancers. Here the authors reveal a synergetic effect between the occurance of two cis mutations in the BARD1 gene affecting the cellular DNA damage response and consequently tumorigenesis.
Guardado en:
Autores principales: | Wenjing Li, Xiaoyang Gu, Chunhong Liu, Yanyan Shi, Pan Wang, Na Zhang, Rui Wu, Liang Leng, Bingteng Xie, Chen Song, Mo Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a37045af7a44a0f82d41c601a782661 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
por: Klaudia Stempa, et al.
Publicado: (2021) -
RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination
por: Qian Zhu, et al.
Publicado: (2021) -
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
por: Yinghua Zhu, et al.
Publicado: (2018) -
A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice
por: Christine Quach, et al.
Publicado: (2019) -
Percolation transition of cooperative mutational effects in colorectal tumorigenesis
por: Dongkwan Shin, et al.
Publicado: (2017)